UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

Clinical trial NCT03933410 · TERMINATED

Trial details

NCT number: NCT03933410
Sponsor: Kaleido Biosciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Urea Cycle Disorder

Start date: 2019-09-17
Primary completion: 2021-02-02
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.